Ironwood Pharmaceuticals, Inc. I76.F Stock
Ironwood Pharmaceuticals, Inc. Price Chart
Ironwood Pharmaceuticals, Inc. I76.F Financial and Trading Overview
Ironwood Pharmaceuticals, Inc. stock price | 7.45 EUR |
Previous Close | 10 EUR |
Open | 10 EUR |
Bid | 10 EUR x 60000 |
Ask | 10.1 EUR x 60000 |
Day's Range | 10 - 10 EUR |
52 Week Range | 9.25 - 12.07 EUR |
Volume | 8 EUR |
Avg. Volume | 0 EUR |
Market Cap | 1.58B EUR |
Beta (5Y Monthly) | 0.920774 |
PE Ratio (TTM) | 11.363636 |
EPS (TTM) | -6.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 13.83 EUR |
I76.F Valuation Measures
Enterprise Value | 1.24B EUR |
Trailing P/E | 11.363636 |
Forward P/E | 6.060606 |
PEG Ratio (5 yr expected) | 0.14 |
Price/Sales (ttm) | 3.7765868 |
Price/Book (mrq) | 2.197802 |
Enterprise Value/Revenue | 2.983 |
Enterprise Value/EBITDA | 4.901 |
Trading Information
Ironwood Pharmaceuticals, Inc. Stock Price History
Beta (5Y Monthly) | 0.920774 |
52-Week Change | -5.27% |
S&P500 52-Week Change | 20.43% |
52 Week High | 12.07 EUR |
52 Week Low | 9.25 EUR |
50-Day Moving Average | 9.75 EUR |
200-Day Moving Average | 10.54 EUR |
I76.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 155.35M |
Float | 136.53M |
Short Ratio | N/A |
% Held by Insiders | 1.81% |
% Held by Institutions | 112.76% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 43.62% |
Operating Margin (ttm) | 60.55% |
Gross Margin | 88.90% |
EBITDA Margin | 60.87% |
Management Effectiveness
Return on Assets (ttm) | 14.10% |
Return on Equity (ttm) | 29.72% |
Income Statement
Revenue (ttm) | 417.13M EUR |
Revenue Per Share (ttm) | 2.72 EUR |
Quarterly Revenue Growth (yoy) | 6.70% |
Gross Profit (ttm) | 366.33M EUR |
EBITDA | 253.94M EUR |
Net Income Avi to Common (ttm) | 181.98M EUR |
Diluted EPS (ttm) | 0.88 |
Quarterly Earnings Growth (yoy) | 17.80% |
Balance Sheet
Total Cash (mrq) | 740.34M EUR |
Total Cash Per Share (mrq) | 4.77 EUR |
Total Debt (mrq) | 415.84M EUR |
Total Debt/Equity (mrq) | 58.83 EUR |
Current Ratio (mrq) | 36.337 |
Book Value Per Share (mrq) | 4.55 |
Cash Flow Statement
Operating Cash Flow (ttm) | 289.81M EUR |
Levered Free Cash Flow (ttm) | 170.66M EUR |
Profile of Ironwood Pharmaceuticals, Inc.
Country | Germany |
State | MA |
City | Boston |
Address | 100 Summer Street |
ZIP | 02110 |
Phone | 617 621 7722 |
Website | https://www.ironwoodpharma.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 219 |
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.
Q&A For Ironwood Pharmaceuticals, Inc. Stock
What is a current I76.F stock price?
Ironwood Pharmaceuticals, Inc. I76.F stock price today per share is 7.45 EUR.
How to purchase Ironwood Pharmaceuticals, Inc. stock?
You can buy I76.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ironwood Pharmaceuticals, Inc.?
The stock symbol or ticker of Ironwood Pharmaceuticals, Inc. is I76.F.
Which industry does the Ironwood Pharmaceuticals, Inc. company belong to?
The Ironwood Pharmaceuticals, Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ironwood Pharmaceuticals, Inc. have in circulation?
The max supply of Ironwood Pharmaceuticals, Inc. shares is 156.53M.
What is Ironwood Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Ironwood Pharmaceuticals, Inc. PE Ratio is now.
What was Ironwood Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Ironwood Pharmaceuticals, Inc. EPS is -6.01 EUR over the trailing 12 months.
Which sector does the Ironwood Pharmaceuticals, Inc. company belong to?
The Ironwood Pharmaceuticals, Inc. sector is Healthcare.